breakthroughs in life science, biotech and biomedical PR
Gable PR team members have been serving life science clients for more than two decades, including developing programs for some of the region’s best known innovators. We understand their fast-paced worlds and our fact-based approach has been proven to help clients break through the hype, grab the attention of the media and analysts while raising positive interest with investors, potential strategic partners, the market, regulators and others.
Former financial journalists and skilled writers probe for the facts and proof of principle that can truly differentiate our clients, then create the compelling stories that build image and reputation creatively and consistently. Gable PR team members have experience, expertise and educational backgrounds in a broad range of technologies. We have counseled clients in biotech, medical technology, life sciences, and drug discovery and development. This, coupled with our long-term relationships with the media, gives us the ability to hit the ground running and generate high visibility with business, investment, general interest and trade press in short order. Start-up clients benefit from our experience in launching some 40 new companies and an integrated approach involving trade shows, new product and technology launches, ramping up for IPOs and subsequent investor relations. Clients have included:
- Pfizer
- GenProbe
- La Jolla Institute for Molecular Medicine
- ResMed
- SeQual Technologies
- Ichor Medical Systems
- PHP Healthcare
- Hybritech
- Forward Ventures
- Biovest Partners
- Burnham Institute
- Sidney Kimmel Cancer Center
- Journal of Clinical Investigation
- Chiron Mimotopes
- Scripps Clinic and Research Foundation
- Scripps Institution of Oceanography
- Neurocrine Biosciences
- Amylin
- Biosite
- Vical
- Alliance Pharmaceutical







